Overview and Scope
Nasal polyps are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infections, allergies, medication sensitivity, and other immunological disorders.
Sizing and Forecast
The nasal polyps treatment market size has grown strongly in recent years. It will grow from <b>$4.83 billion in 2023 to $5.24 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. </b> The growth in the historic period can be attributed to surgical procedures, steroid medications, allergic rhinitis, chronic sinusitis, environmental factors.
The nasal polyps treatment market size is expected to see strong growth in the next few years. It will grow to <b>$7.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. </b> The growth in the forecast period can be attributed to drug development, personalized medicine, telehealth services, patient-centric care, regulatory approvals. Major trends in the forecast period include diagnostic technologies, medical advancements, biologic therapies, immunotherapies, collaborative research.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report
Segmentation & Regional Insights
The nasal polyps treatment market covered in this report is segmented –
1) By Type: Pharmacological Therapies, Surgeries
2) By Route: Oral, Nasal, Other Routes
3) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
<b>North America</b> was the largest region in the nasal polyps treatment market in 2023 <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal polyps treatment market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7109&type=smp
Major Driver Impacting Market Growth
Rising healthcare expenditure is expected to drive the nasal polyps treatment market. Healthcare expenditure refers to the total monetary resources spent by individuals, governments, and organizations within a given healthcare system to cover the costs of medical services, treatments, medications, and healthcare infrastructure. As healthcare budgets expand, there will likely be greater resources allocated to the diagnosis, management, and treatment of nasal polyps. This financial commitment can lead to improved patient access to advanced therapies, innovative treatment options, and enhanced research and development, ultimately fueling the market’s growth. For example, according to the Economic Survey of 2022, an annual document of the Ministry of Finance of the Government of India, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021-22 against 1.8% in 2020-21. Therefore, the rising healthcare expenditure will drive the nasal polyps treatment market.
Key Industry Players
Major companies operating in the nasal polyps treatment market include <b> Sanofi SA, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Cipla Ltd., Circassia Pharmaceuticals plc, Dr. Reddy’s Laboratories Ltd., Genentech Inc., Glenmark Pharmaceuticals Ltd., Johnson & Johnson Services Inc., Lupin Limited, Meda AB, Mundipharma International Limited, Mylan N.V., Novartis AG, Optinose US Inc., Orion Corporation, Pfizer Inc., Regeneron Ireland DAC, Regeneron Pharmaceuticals Inc., Roche Holding AG, Sandoz International GmbH, Stallergenes Greer plc, Sun Pharmaceutical Industries Ltd., Vectura Group plc, Zydus Cadila Ltd. </b>
The nasal polyps treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
